bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
13F holders, Q3 2025
Institutional positions in bioAffinity Technologies, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −5 vs. Q2 2025
- Shares held
- 301.9K
- −60.5K (−16.7%) vs. Q2 2025
- Total value
- $823.7K
- +$719.7K (+691.7%) vs. Q2 2025
- New holders
- 4
- 3 more added
- Sold out
- 9
- 5 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIAF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $782.5K |
| Q1 2026 | 14 | $928.5K |
| Q4 2025 | 9 | $92.5K |
| Q3 2025 | 12 | $823.7K |
| Q2 2025 | 17 | $104.0K |
| Q1 2025 | 17 | $132.3K |
| Q4 2024 | 16 | $497.4K |
| Q3 2024 | 14 | $973.0K |
| Q2 2024 | 17 | $863.3K |
| Q1 2024 | 14 | $484.4K |
| Q4 2023 | 12 | $230.5K |
| Q3 2023 | 10 | $139.7K |
| Q2 2023 | 7 | $177.0K |
| Q1 2023 | 6 | $193.5K |
| Q4 2022 | 5 | $133.5K |
| Q3 2022 | 6 | $192.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding bioAffinity Technologies, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 242,757 | $718.6K | 3.73% | +242,757 | New |
| Scientech Research LLC | 16,583 | $49.1K | 0.02% | +16,583 | New |
| Vanguard Group Inc | 10,429 | $30.9K | 0.00% | −30,213−74.3% | Reduced |
| Tower Research Capital LLC (TRC) | 2,499 | $7.40K | 0.00% | −629−20.1% | Reduced |
| IFP Advisors, Inc | 25,833 | $6.69K | 0.00% | +833+3.3% | Added |
| Allworth Financial LP | 1,791 | $5.30K | 0.00% | −51,943−96.7% | Reduced |
| Bank of America Corp | 1,684 | $4.99K | 0.00% | +1,479+721.5% | Added |
| UBS Group AG | 143 | $423 | 0.00% | +119+495.8% | Added |
| Citigroup Inc | 75 | $222 | 0.00% | −1,403−94.9% | Reduced |
| Larson Financial Group LLC | 33 | $98 | 0.00% | +33 | New |
| FMR LLC | 26 | $77 | 0.00% | +26 | New |
| Morgan Stanley | 3 | $9 | 0.00% | −97−97.0% | Reduced |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −125,459−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −27,885−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −17,600−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,598−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −15,206−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −13,662−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −12,095−100.0% | Sold out |
| Sprott Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |